FDA NDC Directory · JSON-LD · Markdown

Levothyroxine Sodium

NDC 63323-649 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameLEVOTHYROXINE SODIUM ANHYDROUS
Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA202231
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsLEVOTHYROXINE SODIUM ANHYDROUS (100 ug/5mL)
Marketing started20110624
Package count1

External sources

Source: openFDA. Public-domain (CC0).